Connor, Clark & Lunn Investment Management (CC&L)’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.3M Buy
2024
Q2
Sell
2024
Q1
$360K Sell
2023
Q4
$730K Buy
2023
Q3
$330K Buy